Influenza AI Programme (Poolbeg Pharma)

N/A

Report date: 2024/09/14 10:59:32

Base Information

Drug NameInfluenza AI Programme (Poolbeg Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPoolbeg Pharma PLCCytoReason Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCytoReason LtdPoolbeg Pharma PLC
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A